Humoral Immunogenicity of Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study

Detalles Bibliográficos
Autores principales: Riches, Marcie L., Hill, Joshua A., Martens, Michael, Auletta, Jeffery James, Baluch, Aliyah, Bhavsar, Kavita, Brown, Janice (Wes), Dhodapkar, Madhav Vishnu, DiFronzo, Nancy, Howard, Alan, Ibrahim, Uroosa, Nakamura, Ryotaro, Peyton, Kristin, Shahid, Zainab, Sharon, Elad, Spahn, Ashley, Toor, Amir A., Waldvogel, Stephanie, Westervelt, Peter, Young, Jo-Anne H., Perales, Miguel-Angel, Horowitz, Mary M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022
Materias:
Poster Session - Infectious Diseases and Cytotoxic T Lymphocytes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930030/
http://dx.doi.org/10.1016/S2666-6367(22)00635-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930030/
http://dx.doi.org/10.1016/S2666-6367(22)00635-2

Ejemplares similares